Why "GLP-1 Customer" Is Not a Single Segment for Longevity Businesses
Medical Strategy & Clinical Leadership
MD, PhD in Molecular Diagnostics (Cum Laude), with over 27 years of clinical practice in precision, regenerative, functional, and integrative medicine. She is Chief Scientific Officer at Longevity.Tech.fund and Chief Medical Officer at HealthyLongevity.clinic.
For a longevity clinic business model built around GLP-1 patients, this segmentation question determines the entire service design.
GLP-1 customers are becoming a dangerously broad label for longevity businesses. Two people can look identical on paper and need completely different journeys.
Two Patients Who Look the Same on Paper
One patient started a GLP-1 three weeks ago. He is still finding out whether he can tolerate it, what it will cost him long term, and whether he will stay on it. Another patient has been on one for two years. Her questions are different: muscle mass, bone health, maintenance, and what long-term use might look like.
Same Paper, Two Different Journeys
On paper, they look like the same patient. In practice, they require two completely different journeys.
How Fast This Population Is Growing
21% of U.S. households now include a current GLP-1 user, up from 9% sixteen months ago. More importantly, 54% of current users surveyed have now been on them for more than a year, compared with 38% in 2024.
Why the Discontinuation Rate Matters Just as Much
Yet among people who come off GLP-1s, close to two-thirds do so within the first year. That discontinuation pattern matters for anyone building longevity services around this population, because it means the population using these drugs is constantly shifting between early-stage and long-term users.
What Each Stage of User Actually Needs
The person three weeks in may need support with adaptation and adherence. The person two years in may need an entirely different proposition centered on maintaining muscle, monitoring health, and planning for the long term. Putting both under a single “GLP-1 customer” label hides the distinction that actually determines what needs to be built.
The Test for Any GLP-1-Focused Longevity Strategy
If a GLP-1 strategy has one customer represented on a strategy slide, the question to ask is which of the two this represents – the new starter or the long-term user. If the honest answer is both, there is not yet a defined product.
Reading the Distinction Before Capital Is Committed
Reading this distinction clearly, before money is committed to a GLP-1-focused longevity offering, is what separates a business built around a real, defined customer from one built around a label that actually contains two very different populations.
Frequently Asked Questions
Why is "GLP-1 customer" too broad a label for a longevity business to build around?
Because a person three weeks into GLP-1 use and a person two years in look similar on paper but need completely different journeys – one needs adaptation and adherence support, the other needs a maintenance and monitoring proposition.
How large is the GLP-1 user population, and how fast is it growing?
21% of U.S. households now include a current GLP-1 user, up from 9% sixteen months earlier – a population that has grown substantially in a short period.
What percentage of GLP-1 users stay on them long term versus discontinue?
54% of current users have been on them for more than a year, versus 38% in 2024. But among people who come off GLP-1s, close to two-thirds do so within the first year, meaning the population is constantly shifting.
What does a new GLP-1 user need versus a long-term user?
A new user, a few weeks in, typically needs support with adaptation and tolerance. A long-term user, a year or more in, typically needs a different proposition centered on muscle mass, bone health, and maintenance.
How can a longevity business tell if its GLP-1 strategy is actually defined?
Ask which of the two customer types – new starter or long-term user – the strategy is actually built for. If the honest answer is both, the strategy does not yet have a defined product.